doi: 10.6515/ACS.202501_41(1).20240722C
JournalJOURNAL / NEWSLETTER
Volume 41 Number 1 January 2025
1-49 2025 Expert Consensus Recommendations for the Diagnostic Requirements in Routine Practices of Transthoracic Echocardiography
50-54 How To Perform Comprehensive Transthoracic Echocardiography?
doi: 10.6515/ACS.202501_41(1).20241028A
55-71 2025 Update Consensus of 99mTc-Pyrophosphate Scintigraphy in the Transthyretin Cardiac Amyloidosis from the Taiwan Society of Cardiology and the Society of Nuclear Medicine of the Republic of China
doi: 10.6515/ACS.202501_41(1).20241027A
72-81 Rhythm Control Better Prevents Stroke than Rate Control in Patients with Concomitant Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Nationwide Population Based Cohort Study with Long-Term Follow-Up
doi: 10.6515/ACS.202501_41(1).20241111A
82-93 Association of Body Mass Index and Clinical Outcomes in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
doi: 10.6515/ACS.202501_41(1).20241021B
94-105 Feasibility and Safety of Distal Radial Artery Access with Recanalization of a Chronic Radial Artery Occlusion for Subsequent Coronary Angiography and Intervention
doi: 10.6515/ACS.202501_41(1).20241014A
106-120 Real-World Analyses of the De-Escalation of Dual Antiplatelet Therapy in Treatment of Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention in Taiwan
doi: 10.6515/ACS.202501_41(1).20240916B
121-129 Impact of the COVID-19 Pandemic on Door-to-Device Time Segments and Clinical Outcomes for STEMI Patients in Northern Taiwan
doi: 10.6515/ACS.202501_41(1).20241021A
130-137 The Impact of Insulin Resistance on the Development of Post-PCI Contrast-Induced Nephropathy in Non-Diabetic STEMI
doi: 10.6515/ACS.202501_41(1).20241018B
138-147 Inflammatory-Related Biomarkers in Patients Undergoing Percutaneous Transluminal Angioplasty for Femoropopliteal Artery Lesions
doi: 10.6515/ACS.202501_41(1).20241024A
148-152 Lenalidomide-Induced Myocarditis in a Young Male Patient with Multiple Myeloma: A Rare and Life-Threatening Complication of Immunotherapy
doi: 10.6515/ACS.202501_41(1).20241018A
153-157 Instructions for Authors
158-159 Acknowledgement
TOP